1. Ahmed A, Young JB, Gheorghiade M. The underuse of digoxin in heart failure, and approaches to appropriate use. Can Med Assoc J. 2007;176:641-643. 2. Ahmed A, Zannad F, Love TE, Tallaj J, Gheorghiade M, Ekundayo OJ, Pitt B. A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure. Eur Heart J. 2007;28:1334-1343. 3. Ahmed A, Zile MR, Rich MW, Fleg JL, Adams KF Jr, Love TE, Young JB, Aronow WS, Kitzman DW, Gheorghiade M, Dell'Italia LJ. Hospitalizations due to unstable angina pectoris in diastolic and systolic heart failure. Am J Cardiol. 2007;99:460-464. 4. Albert NM, Fonarow GC, Abraham WT, Chiswell K, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB. Predictors of delivery of hospital-based heart failure patient education: a report from OPTIMIZE-HF. J Card Fail. 2007;13:189-198. 5. Arora, R, Ng J, Ulphani J, Mylonas I, Subacius H, Shade G, Gordon D, Morris A, He X, Lu Y, Belin R, Goldberger JJ, Kadish AH. Unique autonomic profile of the pulmonary veins and posterior left atrium. J Am Coll Cardiol. 2007;49: 1340-1348. 6. Arora R, Ulphani JS, Villuendas R, Ng J, Harvey LA, Thordson S, Inderyas F, Lu Y, Gordon D, Denes P, Greene R, Crawford S, Decker RS, Morris A, Goldberger JJ, Kadish AH. Neural substrate for atrial fibrillation: implications for targeted parasympathetic blockade in the posterior left atrium. Am J Physiol Heart Circ Physiol. 2007 [Epub ahead of print] 7. Bax JJ, Inzucchi SE, Bonow RO, Schuijf JD, Freeman MR, Barrett E. Cardiac imaging for risk stratification in diabetes. Diabetes Care 2007:30:1295-1304. 8. Bax JJ, Young LH, Frye RL, Bonow RO, Steinberg HO, Barrett E. Screening for coronary artery disease in patients with diabetes. Diabetes Care 2007;30:2729-2736. 9. Bayes-Genis A, Lloyd-Jones DM, Van Kimmenade R, Lainchbury JG, Richards AM, Ordoñez-Llanos AM, Santaló M, Pinto YM, Januzzi JL. The effect of body-mass index on the diagnostic and prognostic utility of plasma NT-proBNP in patients with acute dyspnea: results from the International Collaborative of NT-proBNP (ICON) Study. Arch Intern Med 2007;167:400-407. 10. Bennett CL, Kim B, Zakarija A, Bandarenko N, Pandey DK, Buffie CG, McKoy JM, Tevar AD, Cursio JF, Yarnold PR, Kwaan HC, Masi DD, Sarode R, Raife TJ, Kiss JE, Raisch DW, Davidson CJ, Sadler E, Ortel TL, Zheng XL, Kato S, Matsumoto M, Uemura M, Fujimura Y. Two mechanistic pathways for thieno-pyridine-associated thrombotic thromb-ocytopenic purpura. J Am Coll Cardiol 2007; 50:1138-1143 11. Beohar N, Davidson CJ, Kip KE, Goodreau L, Vlachos HA, Meyers SN, Benzuly KH, Flaherty JD, Ricciardi MJ, Bennett CL, Williams DO. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA. 2007;297:1992-2000. 12. Beohar N, Flaherty JD, Davidson CJ, Vidovich MI, Brodsky A, Lee DC, Wu E, Bolson EL, Bonow RO, Sheehan FH. Quantitative assessment of regional left ventricular function with cardiac MRI: three-dimensional centersurface method. Catheter Cardiovasc Intervent 2007;69:721-728 13. Beohar N, Flaherty JD, Davidson CJ, Vidovich M, Singhal S, Rapp JA, , Erdogan A, Lee DC, Rammohan C, Brodsky A, Wu E, Pieper K, Virmani R, Bonow RO, MehtaJ. Granulocyte-colony stimulating factor administration after myocardial infarction in a porcine ischemia-reperfusion model: functional and pathological effects of dose timing. Cathet Cardiovasc Intervent 2007;69:257-266. 14. Berliner, JI. The role of multidetector CT in the assessment of myocardial perfusion, infarction, and viability. Appl Radiol. 2007;36:4-15. 15. Berry JD, Lloyd-Jones DM. The clinical implications of obesity: cardiovascular disease. Obesity Management 2007;3:64-68. 16. Berry JD, Lloyd-Jones DM, Wang R, Garside DB, Greenland P. Framingham risk score and prediction of coronary heart disease death in young men. Am Heart J 2007;154:80-86. 17. Berry JD, Lloyd-Jones DM, Wang R, Garside DB, Greenland P. Social avoidance and long-term risk of cardiovascular disease death in healthy men: the Western Electric Study. Ann Epidemiol 2007;17:591-596. 18. Blair JE, Manuchehry A, Chana A, Rossi J, Schrier RW, Burnett JC, Gheorghiade M. Prognostic markers in heart failure: congestion, neurohormones, and the cardiorenal syndrome. Acute Card Care. 2007;24:1-7. 19. Blei AT, Mazhar S, Davidson CJ, Flamm SL, Abecassis M, Gheorghiade M. Hemodynamic evaluation before liver transplantation: insights into the portal hypertensive syndrome. J Clin Gastroenterol. 2007;41:S323-329. 20. Bucciarelli-Ducci C, Denes P, Holly TA, Wu E. Pseudo Wellens T-waves in patients with suspected myocardial infarction: how cardiac magnetic resonance imaging can help the diagnosis. Int J Cardiol 2007 [Epub ahead of print] 21. Burke MA, Ardehali H. Mitochondrial ATP-binding cassette proteins. Transl Res. 2007;150:73-80. 22. Burke MA, Cotts WG. Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions. Heart Failure Reviews. 2007;12:23-36 23. Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V,Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R,Stitzel KF, Stone NJ. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation. 2007;115:114-126. 24. Calfee CS, Shah SJ, Wolters PJ, Saint S, King TE. Clinical problem solving: anchors away. N Engl J Med 2007;365:504-509. 25. Canto JG, Goldberg RJ, Hand MM, Bonow RO, Sopko G, Pepine CJ, Long T. Symptom presentation of women with acute coronary syndromes: myth vs reality. Arch Intern Med 2007;167:2405-2413. 26. Caples SM, Rosen CL, Shen WK, Gami AS, Cotts W, Adams M, Dorostkar P, Shivkumar K, Somers VK, Morgenthaler TI, Stepanski EJ, Iber C. The scoring of cardiac events during sleep. J Clin Sleep Med 2007;3:147-154. 27. Carnethon M, Yan L, Greenland P, Garside DB, Dyer AR, Metzger B, Daviglus ML. Resting heart rate in middle age and diabetes development in older age. Diabetes Care. 2007 [Epub ahead of print] 28. Collins S, Storrow AB, Kirk JD, Pang PS, Diercks DB, Gheorghiade M. Beyond pulmonary edema: diagnostic, risk stratification, and treatment challenges of acute heart failure management in the emergency department. Ann Emerg Med. 2007 [E publish ahead of print] 29. Dasgupta A, Montalvo J, Medendorp S, Lloyd-Jones DM, Ghossein C, Goldberger J, Passman R. Increased complica-tion rates of cardiac rhythm management devices in ESRD patients. Am J Kidney Dis 2007;49:656-663. 30. De Luca L, Fonarow GC, Adams KF Jr, Mebazaa A, Tavazzi L, Swedberg K, Gheorghiade M. Acute heart failure syndromes: clinical scenarios and pathophysiologic targets for therapy. Heart Fail Rev. 2007;12:97-104 31. De Luca L, Fonarow GC, Mebazaa A, Shin DD, Collins SP, Swedberg K, Gheorghiade M. Early pharmacological treatment of acute heart failure syndromes: a systematic review of clinical trials. Acute Card Care. 2007;9:10-21. 32. Denes PA, Larson J, Lloyd-Jones DM, Prineas R, Greenland P. Major and minor ECG abnormalities in asymptomatic women and risk of cardiovascular events and mortality. JAMA 2007;297:978-985. 33. Dev S, Lloyd-Jones DM. Problems associated with screen-ing for asymptomatic cardiac transplant rejection. J Heart Transplant 2007;26:1219. 34. Echols MR, Felker GM, Thomas KL, Pieper KS, Garg J, Cuffe MS, Gheorghiade M, Califf RM, O'Connor CM. Racial differences in the characteristics of patients admitted for acute decompensated heart failure and their relation to outcomes: results from the OPTIME-CHF trial. J Card Fail. 2006;12:684-688. 35. Egger M, Schgoer W, Beer AG, Jeschke J, Leierer J, Theurl M, Frauscher S, Tepper OM, Niederwanger A, Ritsch A, Kearney M, Wanschitz J, Gurtner GC, Fischer-Colbrie R, Weiss G, Piza-Katzer H, Losordo DW, Patsch JR, Schratzberger P, Kirchmair R. Hypoxia up-regulates the angiogenic cytokine secretoneurin via an HIF-1alpha- and basic FGF-dependent pathway in muscle cells. FASEB J. 2007;21:2906-2917. 36. Elkayam U, Tasissa G, Binanay C, Stevenson LW, Gheorghiade M, Warnica JW, Young JB, Rayburn BK, Rogers JG, DeMarco T, Leier CV. Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure. Am Heart J. 2007;153:98-104. 37. Farha S, Asosingh K, Laskowski D, Licina L, Sekigushi H, Losordo DW, Dweik RA, Wiedemann HP, Erzurum SC. Pulmonary gas transfer related to markers of angiogenesis during the menstrual cycle. J Appl Physiol. 2007;103:1789-1795. 38. Filippatos G, Rossi J, Lloyd-Jones DM, Stough WG, Ouyang J, Shin DD, O'connor C, Adams KF, Orlandi C, Gheorghiade M. Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the acute and chronic therapeutic impact of a vasopressin antagonist in chronic heart failure (ACTIV in CHF) study. J Card Fail. 2007;13:360-364. 39. Fletcher GF, Bufalino V, Costa F, Goldstein LB, Jones D, Smaha L, Smith SC Jr, Stone N. Efficacy of drug therapy in the secondary prevention of cardiovascular disease and stroke. Am J Cardiol. 2007;99:1E-35E. 40. Fonarow GC, Abraham WT, Albert NM, Gattis Stough W, Gheorghiade M, Greenberg BH, O'connor CM, Pieper K, Sun JL, Yancy CW, Young JB; for the OPTIMIZE-HF Investigators and Hospitals. Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). Arch Intern Med. 2007;167:1493-1502. 41. Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Pieper K, Sun JL, Yancy C, Young JB; OPTIMIZE-HF Investigators and Hospitals. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA. 2007;297:61-70. 42. Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy C, Young JB; on behalf of the OPTIMIZE-HF Investigators and Coordinators. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: An analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J. 2007;153:82.e1-82.e11. 43. Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O’Connor CM, Sun JL, Yancy CW, Young JB; on behalf of the OPTIMIZE-HF Investigators and Coordinators. Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF. J Card Fail. 2007:73; 722-731. 44. Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, O’Connor CM, Sun JL, Yancy CW, Young JB; OPTIMIZE-JF Investigators and Hospitals. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-JF Registry. J Am Coll Cardiol. 2007:50; 768-777. 45. Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, Mehra M, O'Connor CM, Reynolds D, Walsh MN. Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry. Am Heart J. 2007;154:12-38. 46. Friedewald VE, Bonow RO, Borer JS, Carabello BA, Kleine PB, Akins CW, Roberts WC. The editor’s roundtable: cardiac valve surgery. Am J Cardiol 2007;99:1269-1278 47. Friedewald VE, Gheorghiade M, Yancy CW, Young JB, Roberts WC.The editor's roundtable: acute decompensated heart failure. Am J Cardiol. 2007;99:1560-7. 48. Fus AM, Kim MH, Haw JM, Trohman RG, Stephan E. A written policy increases compliance with guidelines for therapeutic anticoagulation prior to elective direct current cardioversion of atrial fibrillation. J Cardiovasc Nursing 2007;22:417-421. 49. Gargani L, Frassi F, Soldati G, Tesorio P, Gheorghiade M, Picano E. Ultrasound lung comets for the differential diagnosis of acute cardiogenic dyspnoea: a comparison with natriuretic peptides. Eur J Heart Fail. 2007 [Epub ahead of print] 50. Ghali JK, Smith WB, Torre-Amione G, Haynos W, Rayburn BK, Amato A, Zhang D, Cowart D, Valentini G, Carminati P, Gheorghiade M. A phase 1-2 dose-escalating study evaluating the safety and tolerability of istaroxime and specific effects on electrocardiographic and hemodynamic parameters in patients with chronic heart failure with reduced systolic function. Am J Cardiol. 2007;99:47A-56A. 51. Gheorghiade M, Abraham WT, Albert NM, Gattis Stough W, Greenberg BH, O'connor CM, She L, Yancy CW, Young J, Fonarow GC. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J. 2007;28:980-988. 52. Gheorghiade M, Fonarow GC. Management of post-myocardial infarction patients with left ventricular systolic dysfunction. Am J Med. 2007;120:109-120. 53. Gheorghiade M, Konstam MA, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C: Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA. 2007;297:1332-1343. 54. Gheorghiade M, Rossi JS, Cotts W, Shin DD, Helkamp AS, Pina IL, Fonarow GC, DeMarco T, Pauly DF, Rogers J, DiSalvo TG, Butler J, Hare JM, Francis GS, Stough WG, O’Connor CM. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med. 2007:167;1998-2005. 55. Gheorghiade M, Sabbah HN. Istaroxime: an investigational luso-inotropic agent for acute heart failure syndromes. Am J Cardiol. 2007;99:1A-3A. 56. Gold MR, Niazi I, Giudicci M, Leman RB, Sturdivant JL, Kim MH, Yu Y, Ding J, Waggoner AD. A prospective comparison of AV delay programming methods for hemodynamic optimization during cardiac resychronization therapy. J Cardiovasc Electrophysiol 2007;8:1-7. 57. Goldberger JJ, Greenstein E. Fragmented QRS for risk prediction: picking up the pieces. Heart Rhythm. 2007;4:1393-1394. 58. Goldberger JJ, Subacius H, Sen-Gupta I, Johnson D, Kadish AH, Ng J. A new method to determine the electrical transfer function of the human thorax. Am J Physiol Heart Circ Physiol. 2007;293:H3440-H3447. 59. Goukassian DA, Qin G, Dolan C, Murayama T, Silver M, Curry C, Eaton E, Luedemann C, Ma H, Asahara T, Zak V, Mehta S, Burg A, Thorne T, Kishore R, Losordo DW. Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization. Circulation. 2007;115:752-762. 60. Gould KL, Pan T, Loghin C, Johnson NP, Guha A, Sdringola S. Frequent diagnostic errors in cardiac PET/CT due to misregistration of CT attenuation and emission PET images: a definitive analysis of causes, consequences, and corrections. J Nucl Med 2007;48:1112-1121 61. Gerstenfeld EP, Jacobson J, Bazan V, Lazar S, Tomaszewski JE, Marchlinski FE, Michele J. Comparison of high power, medium power, and irrigated-tip ablation strategies for pulmonary vein isolation in a canine model. J Cardiovasc Electrophysiol. 2007;18:849-53 62. Greenberg BH, Abraham WT, Albert NM, Chiswell K, Clare R, Stough WG, Gheorghiade M, O'Connor CM, Sun JL, Yancy CW, Young JB, Fonarow GC. Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving reatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J. 2007;154:1-8. 63. Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grundy SM, Lauer MS, Post WS, Raggi P, Redberg RF, Rodgers GP. Shaw LJ, Taylor AJ, Weintraub WS. ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Computed Tomography for the Diagnosis and Prognosis of Coronary Artery Disease. J Am Coll Cardiol 2007;49:378-402 and Circulation 2006; 115:402-426. 64. Greenland P, Lloyd-Jones DM. Time to end the mixed – and often incorrect – messages about prevention and treatment of atherosclerotic cardiovascular disease. J Am Coll Cardiol 2007; 50: 2133-2135. 65. Grines CL, Bonow RO, MD, Casey DE, Jr., Gardner TE, MD, Lockhart P, Moliterno DJ, O’Gara PT, Whitlow P. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents. Circulation 2007;115;813-818, J Am Coll Cardiol 2007;49:734-739, and J Am Dental Assoc 2007;138:652-655. 66. Gupta R, Plantinga LC, Fink NE, Melamed ML, Coresh J, Fox CS, Levin NW, Powe NR. Statin use and hospitalization for sepsis in patients with chronic kidney disease. JAMA. 2007;297:1455-1464. 67. Hammill SC, Stevenson LW, Kadish AH, Kremers MS, Heidenreich P, Lindsay BD, Mirro MJ, Radford MJ, Wang Y, Lang CM, Harder JC, Brindis RG. Review of the registry's first year, data collected, and future plans. Heart Rhythm. 2007;4:1260-1263. 68. Hsia J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P, Heckbert SR, Johnson KC, Manson JE, Sidney S, Trevisan M. Women's health initiative investigators. Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007;115:846-854. 69. Ilkhanoff L, Gerstenfeld EP, Zado E, Marchlinski FE. Changes in ventricular dimensions and function during recovery of atrial tachycardia induced cardiomyopathy treated with catheter ablation. J Cardiovasc Electro-hysiol. 2007;18:1104-1106. 70. Januzzi JL, Peacock WF, Maisel AS, Chae CU, Jesse RL, Baggish AL, O’Donoghue M, Sakhuja R, Chen AA, van Kimmenade RRJ, Lewandrowski KB, Lloyd-Jones DM, Wu AHB. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol 2007;50:607-613. 71. Kadish AH. Can ICDs prevent sudden cardiac death effectively in patients with hypertrophic cardiomyopathy? Nat Clin Pract Cardiovasc Med. 2007 [Epub ahead of print] 72. Kadish AH. Predicting tilt table results. Heart Rhythm. 2007;4:1383-1384. 73. Kerns, SL, Torke, SJ, Benjamin, JM, McGarry, TJ. Geminin prevents re-replication during Xenopus develoment. J Biol Chem 2007;282:5514-5521. 74. Khush KK, Shah SJ, Ristow B, De Marco T, Schiller NB, Whooley MA. Association of African-American race with elevated pulmonary artery diastolic pressure: data from the Heart and Soul Study. J Am Soc Echocardiogr 2007;20: 1307-1313. 75. Kim MH, Christiansen S, Harsch M, Kinser K, Pfeiffer J. Value of pacemaker arial diagnostic data in patients with paroxysmal atrial fibrillation: an opportunity to improve rates of warfarin utilization. PACE 2007;30:1-4. 76. Kirchmair R, Tietz AB, Panagiotou E, Walter DH, Silver M, Yoon YS, Schratzberger P, Weber A, Kusano K, Weinberg DH, Ropper AH, Isner JM, Losordo DW. Therapeutic angiogenesis inhibits or rescues chemotherapy-induced reripheral neuropathy: taxol- and thalidomide-induced injury of vasa nervorum is ameliorated by VEGF. Mol Ther. 2007;15:69-75. 77. Kizilbash MA, Carnethon MR, Chan C, Jacobs DR, Lloyd-Jones DM, Sidney S, Liu K. The association of heart rate recovery immediately after exercise with coronary artery calcium: Coronary Artery Risk Development in Young Adults Study. Clin Autonomic Res 2007; 17:46-49. 78. Klein L, O’Connell JB. Thromboembolic risk in the patient with heart failure, Curr Treat Options Cardiovasc Med. 2007;9:310-317. 79. Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C: Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007;297:1319-1331. 80. Kumar A, Lloyd-Jones DM. Prevalence and significance of isolated minor non-specific ST-segment and T-wave abnormalities. Cardiology in Review 2007;15:133-142. 81. Kusano K, Tsutsumi Y, Dean J, Gavin M, Ma H, Silver M, Thorne T, Zhu Y, Losordo DW, Aikawa R. Long-term stable expression of human growth hormone by rAAV promotes myocardial protection post-myocardial infarction. J Mol Cell Cardiol. 2007;42:390-399. 82. LaBresh KA, Fonarow GC, Smith SC, Bonow RO, Robertson RM, Smaha LA, Tyler PA, Skea W, Hong Y, Emond J, Albright D, Ellrodt G. Get With The Guidelines for cardiovascular disease: initial results from the American Heart Association’s national program. Crit Pathways Cardiol. 2007;6:98-105. 83. Leyngold I, Baughman K, Kasper E, Ardehali H. Comparison of survival among patients with connective tissue disease and cardiomyopathy (systemic sclerosis, systemic lupus erythematosus, and undifferentiated disease). Am J Cardiol. 2007;100:513-517. 84. li M, Losordo DW. Statins and the endothelium. Vascul Pharmacol. 2007;46:1-9. 85. Lin D, Garcia F, Jacobson J, Gerstenfeld EP, Dixit S, Verdino RJ, Callans DJ, Marchlinski FE. Use of non-contact mapping and saline cooled ablation catheter for sinus node modification in medically refractory inappropriate sinus tachycardia. Pacing and Electrophysiology. 2007;30:236-242. 86. Liu X, Simpson J, Brunt KR, Barrette V, Ward CA, Tse Y, Pang SC, Pachori AS Dzau V J, Ogunyankin KO, Melo LG. Pre-emptive heme oxygenase-1 gene delivery reveals reduced mortality and preservation of left ventricular function one year after acute myocardial infarction. Am J Physiol Heart Circ Physiol. 2007;293:H48-59. 87. Lloyd-Jones DM, Dyer AR, Wang R, Daviglus ML, Greenland P. Risk factor burden in middle age and lifetime risks for cardiovascular and non-cardiovascular death: Chicago Heart Association Detection Project in Industry. Am J Cardiol 2007;99:535-540. 88. Lloyd-Jones DM, Liu K, Colangelo LA, Yan LL, Klein L, Loria CM, Lewis CE, Savage P. Consistently stable body mass index and changes in risk factors associated with the metabolic syndrome. Circulation. 2007;115:1004-1011. 89. Loh Y, Oyama Y, Statkute L, Traynor A, Satkus J, Quigley K, Yaung K, Barr W, Bucha J, Gheorghiade M, Burt RK. Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus patients with cardiac dysfunction: feasibility and reversibility of ventricular and valvular dysfunction with transplant-induced remission. Bone Marrow Transplant. 2007;40:47-53 90. Loria C, Liu K, Colangelo L, Lloyd-Jones D, Daviglus M, Savage P, Lewis CE. Initial body mass index in young adults predicts 20-year risk of incident diabetes: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Circulation 2007;115:1004-1011. 91. Losordo DW, Schatz RA, White CJ, Udelson JE, Veereshwarayya V, Durgin M, Poh KK, Weinstein R, Kearney M, Chaudhry M, Burg A, Eaton L, Heyd L, Thorne T, Shturman L, Hoffmeister P, Story K, Zak V, Dowling D, Traverse JH, Olson RE, Flanagan J, Sodano D, Murayama T, Kawamoto A, Kusano KF, Wollins J, Welt F, Shah P, Soukas P, Asahara T, Henry TD. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation. 2007;115:3165-3172. 92. Lynch E, Liu K, Spring B, Hankinson A, Wei GS, Greenland P. Association of ethnicity and socioeconomic status with judgments of body size: the coronary artery risk development in young adults (CARDIA) study. Am J Epidemiol. 2007;165:1055-1062. 93. Maruyama K, Asai J, Ii M, Thorne T, Losordo DW, D'Amore PA. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol. 2007;170: 1178-1191. 94. Morello A, Lloyd-Jones DM, Chae CU, van Kimmenade RRJ, Chen AC, Baggish AL, O’Donoghue M, Januzzi JL. Association of atrial fibrillation with amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. Am Heart J 2007;153:90-97. 95. Mosca L, Banka CL, Benjamin EJ, Berra K, Bushnell C, Dolor RJ, Ganiats TG,Gomes AS, Gornik HL, Gracia C, Gulati M, Haan CK, Judelson DR, Keenan N,Kelepouris E, Michos ED, Newby LK, Oparil S, Ouyang P, Oz MC, Petitti D, Pinn VW,Redberg RF, Scott R, Sherif K, Smith SC Jr, Sopko G, Steinhorn RH, Stone NJ, Taubert KA, Todd BA, Urbina E, Wenger NK. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation. 2007;115:1481-1501. 96. Mosley WJ, Greenland P, Garside D, Lloyd-Jones DM. Predictive utility of pulse pressure and other blood pressure measures for cardiovascular outcomes. Hypertension 2007;49:1256-1264. 97. Nasir K, Budoff MJ, Wong ND, Scheuner M. Herrington D, Arnett DK, Szklo M, Greenland P, Blumenthal RS. Family history of premature coronary heart disease and coronary artery calcification: Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2007;116:619-626. 98. Ng J, Goldberger JJ. Understanding and interpreting dominant frequency analysis of AF electrograms. J Cardiovasc Electrophysiol.2007;18:680-685. 99. Ng J, Kadish AH, Goldberger JJ. Technical considerations for dominant frequency analysis. J Cardiovasc Electro-physiol. 2007;18:757-764. 100. Ogunyankin KO, Day AG, Lonn E. Cardiac function stratification based on echocardiographic or clinical markers of left ventricular filling pressures predicts death and hospitalization better than stratification by ventricular systolic function alone. Echocardiography 2007 [Epub ahead of print] 101. Ortiz Pérez JT, Meyers SN, Lee DC, Kansal P, Klocke FJ, Holly TA, Davidson CJ, Bonow RO, Wu E. Angiographic estimates of myocardium at risk during acute myocardial infarction: validation study using cardiac magnetic resonance imaging. Eur Heart J 2007;28:1750-1758 102. Passman R, Kadish AH. Sudden death prevention with implantable devices. Circulation. 2007;116:561-571 103. Passman R, Subacius H, Ruo B, Schaechter A, Howard A, Sears S, Kadish A. Implantable cardioverter defibrillators and quality of life: results from the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Study. Arch Intern Med 2007;167:2226-2232. 104. Quraishi A, Losordo DW. Ischemic tissue repair by autologous bone marrow-derived stem cells: scientific basis and preclinical data. Handb Exp Pharmacol. 2007;167-179. 105. Rajamannan NM, Bonow RO, Rahimtoola SH. Calcific aortic stenosis: an update. Nat Clin Pract Cardiovasc Med 2007;4:254-262. 106. Racker DK. Topography of the AV node and the left-sided His bundle recordings. Heart Rhythm 2007;4:384-385. 107. Rajasingh J, Bord E, Hamada H, Lambers E, Qin G, Losordo DW, Kishore R. STAT3-dependent mouse embryonic stem cell differentiation into cardiomyocytes: analysis of molecular signaling and therapeutic efficacy of cardiomyocyte precommitted mES transplantation in a mouse model of myocardial infarction. Circ Res. 2007;101:910-918. 108. Rajasingh J, Bord E, Qin G, Ii M, Silver M, Hamada H, Ahluwalia D, Goukassian D, Zhu Y, Losordo DW, Kishore R. Enhanced voluntary alcohol consumption after estrogen supplementation negates estrogen-mediated vascular repair in ovariectomized mice. Endocrinology. 2007;148:3618-3624. 109. Rapp JA, Gheorghiade M. Role of neurohormonal modulators in heart failure with relatively preserved systolic function. Heart Fail Clin. 2005;1:77-93. 110. Reddy VK, Villuendas R, Rudin A, Goldberger JJ, Kadish AH. Cryomap failure. J Interv Card Electrophysiol. 2007;19:139-141. 111. Renault MA, Losordo DW. Therapeutic myocardial angiogenesis. Microvasc Res. 2007;74:159-171. 112. Renault MA, Losordo DW. The matrix revolutions: matrix metalloproteinase, vasculogenesis, and ischemic tissue repair. Circ Res. 2007;100:749-750. 113. Rigolin VH, Bonow RO. Hemodynamic characteristics and progression to heart failure in regurgitant lesions. Heart Failure Clin 2007;2:453-460 114. Robinson JG, Bakris G, Torner J, Stone NJ, Wallace R. Is it time for a cardiovascular primary prevention trial in the elderly? Stroke. 2007;38:441-450. 115. Roncalli J, Carrie D, Fauvel JM, Losordo DW. A "hawk's beak" to identify the new transient midventricular Tako-Tsubo syndrome. Int J Cardiol. 2007 [Epub ahead of print] 116. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y. Heart Disease and Stroke Statistics--2007 Update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115:e69-e171. 117. Rossi J, Bayram M, Udelson JE, Lloyd-Jones D, Adams KF, Oconnor CM, Stogh Wg, Ouyang J, Shin DD, Orlandi C, Gheorghiade M. Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial. Acute Cardiac Care 2007;9:82-86. 118. Rossi J, Orlandi C, Gheorghiade M. Vasopressin antagonists in the management of heart failure. Exp Rev Cardiovasc Ther. 2007;5:323-330. 119. Russell RR, Abbott BG, Arrighi JA, Bengel FM, Cohen MC, Garcia EV, Hendel RC, Holly TA, Mieres JH, Shaw LJ, Thomas GS, Thompson RC, Wackers FJ, Bax JJ. Highlights of the 2007 Scientific Sessions of the American Society of Nuclear Cardiology: San Diego, California, September 6–9, 2007. J Am Coll Cardiol 2007;50:2336-2343. 120. Sabbah HN, Imai M, Cowart D, Amato A, Carminati P, Gheorghiade M. Hemodynamic properties of a new-generation positive luso-inotropic agent for the acute treatment of advanced heart failure. Am J Cardiol. 2007;99:41A-46A. 121. Shah SJ, Ingraham AO, Chung SY, Haber RJ. Clinical conundrums: a distinguishing feature. J Hosp Med 2007;2:39-45. 122. Shah SJ, Marcus GM, Gerber IL, McKeown BH, Vessey JC, Jordan MV, Huddleston M, Foster E, Chatterjee K, Michaels AD. Physiology of the third heart sound: novel insights from tissue Doppler imaging. J Am Soc Echocardiogr 2007 [Epub ahead of print] 123. Shah SJ, Ristow B, Ali S, Na B, Schiller NB, Whooley MA. Acute myocardial infarction in patients with versus without aortic valve sclerosis and effect of statin therapy (from the Heart and Soul Study). Am J Cardiol 2007;99:1128-1123. 124. Shah SJ, Teerlink JR. Nesiritide: A reappraisal of efficacy and safety. Expert Opin Phrmracother 2007;8:361-369. 125. Shin DD, Brandimarte F, De Luca L, Sabbah HN, Fonarow GC, Filippatos G, Komajda M, Gheorghiade M. Review of current and investigational pharmacologic agents for acute heart failure syndromes. Am J Cardiol. 2007;99:4A-23A. 126. Stone NJ, Schmeltz LR. Metabolic syndrome management. Expert Opin Pharmacother. 2007;8:2059-2075. 127. Sui X, Gheorghiade M, Zannad F, Young JB, Ahmed A. A propensity matched study of the association of education and outcomes in chronic heart failure. Int J Cardiol. 2007 [Epub ahead of print] 128. Sun L, Shukair S, Naik TJ, Moazed F, Ardehali H. Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinase I and II. Mol Cell Biol. 2007 [Epub ahead of print] 129. Sundaram S, Carnethon M, Polito K, Kadish AH, Goldberger JJ. Autonomic effects on QT-RR interval dynamics after exercise. Am J Physiol Heart Circ Physiol. 2007 [Epub ahead of print] 130. Takeshita K, Satoh M, Ii M, Silver M, Limbourg FP, Mukai Y, Rikitake Y, Radtke F, Gridley T, Losordo DW, Liao JK. Critical role of endothelial Notch1 signaling in postnatal angiogenesis. Circ Res. 2007;100:70-78. 131. Tang Z, Diamond MA, Chen JM, Holly TA, Bonow RO, Dasgupta A, Hyslop T, Purzycki A, Wagner J, McNamara DM, Kukulski T, Wos S, Velazquez EJ, Ardlie K, Feldman AM. Polymorphisms in adenosine receptor genes are associated with infarct size in patients with ischemic cardiomyopathy. Clin Pharmacol Ther 2007;82:435-440. 132. Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Resp J 2007;30:1103-10. 133. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow RO, Van Der Wall EE, Bassand JP, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfinkel EP, Lopez-Sendon JL, Pais P, Mendis S, Zhu JR, Wallentin LC, Fernandez-Avilés F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio-Pulkki LM. Universal definition of myocardial infarction. The Joint ESC/ACC/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Eur Heart J 2007;28:525-538; J Am Coll Cardiol 2007; and Circulation 2007;116:2634-2653 134. Tongers J, Losordo DW. Frontiers in nephrology: the evolving therapeutic applications of endothelial progenitor cells. J Am Soc Nephrol. 2007;18:2843-2852. 135. Ulphani JS, Arora R, Cain JH, Villuendas R, Shen S, Gordon D, Inderyas F, Harvey LA, Morris A, Goldberger JJ, Kadish AH. The ligament of Marshall as a parasympathetic conduit. Am J Physiol Heart Circ Physiol. 2007;293:H1629-1635. 136. Ulphani JS, Ng J, Aggarwal R, Cain JH, Gordon D, Yang E, Morris AR, Arora R, Goldberger JJ, Kadish AH. Frequency gradients during two different forms of fibrillation in the canine atria. Heart Rhythm. 2007;4:1315-1323. 137. Vassallo P, Trohman RG. Prescribing amiodarone: an evidence-based review of clinical indications. JAMA. 2007; 298:1312-1322. 138. Velazquez EJ, Lee KL, O’Connor CM, Oh JK, Bonow RO, Pohost GM, Feldman AM, Mark DB, Panza JA, Sopko G, Rouleau JL, Jones RH. The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) Trial. J Thorac Cardiovasc Surg 2007;134:1540-1547. 139. Wang TJ, Kathiresan S, Lloyd-Jones DM. Algorithms for assessing cardiovascular risk in women. JAMA 2007;298: 176. 140. Weinberg KM, Denes P, Kadish AH, Goldberger JJ. Criteria for the electrocardiographic diagnosis of atrial flutter improve diagnostic accuracy. Am J Med. 2007;120:814-818. 141. Wilcox CM, Allison J, Benzuly K, Borum M, Cryer B, Grosser T, Hunt R, Ladabaum U, Lanas A, Paulus H, Regueiro C, Sandler RS, Simon L. Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin. Clin Gastroenterol Hepatol. 2006;4:1082-1089. 142. Wilson W, Taubert KA, Gewitz M, Lockhart P, Baddour LM, Levison M, Bolger A, Cabell CH, Takahashi M, Baltimore RS, Newburger JW, Strom BI, Tani LY, Gerber M, Bonow RO, Pallasch T, Shulman ST, Rowley AH, Burns JC, Ferrieri P, Gardner T, Goff D, Durack DT. Prevention of infective endocarditis: recommendations from the American Heart Association. Circulation 2007;116:1736-1754 and J Am Dental Assoc 2007;138:739-760 143. Wu E, Ortiz JT, Tejedor P, Lee DC, Bucciarelli-Ducci C, Kansal P, Carr JC, Holly TA, Lloyd-Jones D, Klocke FJ, Bonow RO. Infarct size by contrast enhanced cardiac mag-netic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart. 2007 [Epub ahead of print] 144. Xiao L*, Zhao Q*, Du Y, Chao Y, Solaro RJ, Buttrick PM: PKCe increases phosphorylation of cardiac myosin binding protein C at serine302 both in vitro and in vivo. Biochemistry 2007; 46:7054-7061, (* Co-first author) 145. Zhao Q, Geha AS, Devries SR, Tshibaka C, Wu SJ, Lavi N, Massad M, Chomka EV. Biatrial primary synovial sarcoma of the heart. J Am Soc Echocardiogr. 2007;20:197.e1-4.
1. Devries S, Conkling J. What Your Doctor May Not Tell You About Cholesterol. New York: Time/Warner, 2007:pp224 2. Libby P, Bonow RO, Mann D, Zipes DP, eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 8th Edition. Philadelphia: Elsevier Science, 2007:pp2183 3. Lipsky M, Mendelson M, Havas S, Miller, M, eds. Guide To Preventing and Treating Heart Disease. New Jersey: John Wiley & Sons, Inc, 2007:pp328 4. Mebazaa A, Parrillo JE, Gheorghiade M, eds. Acute Heart Failure. New York: Springer Verlag, 2007: pp800
1. Davidson CJ, Bonow RO. Cardiac catheterization. In: Libby P, Bonow RO, Mann DL, Zipes DP, eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 8th Edition. Philadelphia: Elsevier Science 2007:439-463 2. Emanuel LL, Bonow RO. Care of patients with end-stage heart disease. In: Libby P, Bonow RO, Mann DL, Zipes DP, eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 8th Edition. Philadelphia: Elsevier Science, 2007:717-725 3. Hauser J, Bonow RO. Heart failure and palliative care. In: Emanuel LL, Librach SL, eds. Palliative Care: Core Skills and Clinical Competencies. Philadelphia: Saunders/Elsevier, 2007:340-354 4. Jacobson JT, David Lin, Ralph Verdino, Joshua Cooper, Marchlinski FE. Ablation of ventricular tachycardia associated with nonischemic structural heart disease. In Wilber DJ, Packer DL, Stevenson WG, eds. Catheter Ablation of Cardiac Arrhythmias, 3rd Edition. Futura, New York, 2007:p22 5. Lee T, Bonow RO. Guidelines for valvular heart disease. In: Libby P, Bonow RO, Mann DL, Zipes DP, eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 8th Edition. Philadelphia: Elsevier Science, 2007:1693-1712 6. Lloyd-Jones DM, Greenland P. Blood pressure and the risks of cardiovascular disease and stroke. In: Comprehensive Hypertension. Lip GYH, Hall JE, eds. Philadelphia: Mosby Elsevier, 2007:51-62. 7. Lloyd-Jones DM, Levy D. Epidemiology of hypertension. In: Black HR, Elliott WJ, eds Hypertension – A Companion to Braunwald’s Textbook of Cardiovascular Medicine. Philadelphia: Saunders Elsevier, 2007:3-14. 8. Otto CM, Bonow RO. Valvular heart disease. In: Libby P, Bonow RO, Mann DL, Zipes DP, eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 8th Edition. Philadelphia: Elsevier Science, 2007:1625-1693 9. Ricciardi MJ, Robbins JD, Flaherty JD, Davidson CJ. Renal Failure, Diabetics. In: Kern MJ, ed. SCAI Interventional Cardiology Board Review Book. Lippincott Williams & Wilkins 2007:215-224. 10. Rossi J, Gheorghiade M. Is there still a role for digitalis in heart failure? In: Abraham WT, Krum H, eds. Heart Failure: A Practical Approach to Treatment. New York: McGraw-Hill, 2007 11. Stone, NJ. Diet and nutritional issues. In: Topol EJ, ed. Textbook of Cardiovascular Medicine, 3rd Edition, Philadelphia: Lippincott Wiliiams and Wilkins, 2007. 12. Stone NJ. Drugs for elevated LDL cholesterol. In: Antman E, ed. Cardiovacular Therapeutics. A Companion to Braunwald’s Heart Disease, 3rd Edition, Philadelphia: WB Saunders 2007:528-539. 13. Stone NJ, Berliner J. The metabolic syndrome defined. In: Packer L, Cadenas E, eds; Oxidative Stress and Inflammatory Mechanisms in Obesity, Diabetes, and the Metabolic Syndrome, Boac Raton CRC Press (Taylor and Frances Group), 2007:3-14 14. Udelson JE, Dilsizian V, Bonow RO. Nuclear cardiology. In: Libby P, Bonow RO, Mann DL, Zipes DP, eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 8th Edition. Philadelphia: Elsevier Science, 2007:345-388 1. Adams KF, Baughman Chronic Heart Failure (ACTIV in CHF) study. J Card Fail. 20 Gheorghiade M, Sabbah HN. Istaroxime: an investigational luso-inotropic agent for acute heart failure syndromes. Am J Cardiol. 2007;99:1A-3A. 2. Albert NM, Fonarow GC, O’Connoer CM, Stough WG, Nunez E, Abraham WT, Gheorghiade M, Greenberg BH, Yancy CW, Young JB. Is history of depression a predictor of in-hospital treatment and early post-discharge outcomes in patients with heart failure? J Card Fail 2007;13:S162. 3. Allison MA, Manson J, Langer R, Carr JJ, Rossouw J, Cochrane B, Eaton C, Greenland P, Hendrix S, Hsia J, Hunt J, Jackson R, Johnson K, Kuller L, Phillips L, Robinson J. History of oophorectomy is associated with higher risk of subclinical coronary artery disease in women with hysterectomy. Circulation 2007;115:e286. 4. Amin, A.P., Nathan, S., Vassallo, P., Calvin, J.E. Diagnostic performance of the modified Rush score across risk strata and pre-specified clinical subgroups, is superior to the TIMI risk score for rrediction of in-hospital mortality in acute coronary syndromes (ACS). J Am Coll Cardiol 2007; 49:239A. 5. Arora R, Villuendas R, Ng J, Goldstein J, Mottl S, Zhou R, Dean D, Gordon D, Gilchrist A, Aistrup G, Goldberger J, Kadish A. Targeted G-protein inhibition in the posterior left atrium- a novel method to selectively inhibit parasympathetic signaling in the left atrium. Heart Rhythm 2007;4:S9-S10. 6. Belin R, Mottl S, Goldstein J, Angulo A, Salwan A, Villuendas R, Aistrup G, Goldberger J, Kadish A, Arora R. Molecular basis for sympathetic remodeling in the left atrium in the ventricular tachypacing canine model of congestive heart failure. Circulation 2007;116; II-251. 7. Belin RJ, Psaty BM, Manolio TA, Newman AB, Heckbert SR, Lloyd-Jones DM. Impact of subclinical CVD and inflammation on the occurrence of CVD events and mortality in elderly subjects with incident atrial fibrillation in the Cardiovascular Health Study. Circulation 2007;116: e272. 8. Beohar N, Pang J, Meyers SN, Kim D, Lloyd-Jones D, Yaghmai V: Detection of stent fractures: a comparison of 64-MSCT, conventional cine-angiography, and intravascular ultrasonography. Radiology. 2007; 9. Berry JD, Garside DB, Cai X, Dyer AR, Lloyd-Jones DM. Remaining lifetime risks for cardiovascular disease death by risk factor burden at selected ages in black and white men and women. Circulation 2007;116:II-832. 10. Berry JD, Liu K, Folsom AR, Lewis CE, Carr JJ, Polak J, Shea SJ, Sidney S, O'Leary DH, Chan C, Lloyd-Jones DM. Prevalence and progression of subclinical atherosclerosis in younger adults with low predicted short-term but high lifetime risk for cardiovascular disease: findings from the CARDIA and MESA studies. Circulation 2007;116:II-788. 11. Berry JD, Lloyd-Jones DM. Estimating lifetime risk for cardiovascular disease in men and women: How well does the Framingham Risk Score add up? Circulation 2007;116:II-829. 12. Burke, M.A., Ardehali, H. 2007. Snf1-related kinase (SNRK) is upregulated in ischemic tissue, and its overexpression increases cell death. Circ Res 2007;101:E61. 13. Carnethon MR, Lloyd-Jones DM, Dyer AR, Daviglus ML, Garside DB, Greenland P. Differences in the association of ECG abnormalities with 32-year CHD mortality in black and white men and women. Circulation 2007;115:e289. 14. Chandra S, Shah SJ, Thenappan T, Rich S, Gomberg-Maitland M. Diffusing capacity predicts mortality in pulmonary arterial hypertension. Am J Resp Crit Care Med 2007;175:A714. 15. Eimer MJ, Johnson NP, Leonard SM, Holly TA, Cotts W, Bonow RO, Mottola L, Puthumana JJ. Shortened time to peak filling rate precedes left ventricular systolic dysfunction in chemotherapy induced cardiomyopathy. J Nucl Cardiol 2007;14:S103. 16. Faiez Z, Wang NC, Konstam MA, Bechhofer R, Gheorghiade M, Burnett JC, Grinfeld L, Swedberg K, Udelson JE, Cook T, Ouyang J, Zimmer C, Orlandi C, Maggioni AP. Regional differences in baseline characteristics and outcomes in patients hospitalized with worsening heart failure and systolic dysfunction. J Card Fail 2007;13:S77. 17. Flaherty JD, Rossi JS, Davidson CJ et al for the OPTIMIZE-HF Investigators. Coronary revascularization status and survival in acute heart failure: a report from OPTIMIZE-HF. Eur Heart J 2007;28:S389-390. 18. Flaherty JD, Rossi JS, Davidson CJ, Nunez E, Stough WG, Abraham WT, Albert NM, Greenberg BH, O’Connor CM, Yancy CW, Young JB, Fanarow GC, Gheorghiade M. Influence of etiology and left ventricular systolic function on acute heart failure outcomes: A Report from OPTIMIZE-HF. J Am Coll Cardiol;2007;49:71A. 19. Fonarow GC, Albert NM, O’Conner CM, Stough WG, Nunez E, Abraham WT, Gheorghiade M, Greenberg BH, Yancy CW, Young. Does the day of the week heart failure patients are admitted influence length of stay or mortality risk? Findings from OPTIMIZE-HF. J Card Fail 2007; 13:S174. 20. Fonarow GC, Albert NM, O’Conner CM, Stough WG, Nunez E, Abraham WT, Gheorghiade M, Greenberg BH, Yancy CW, Young JB. Predictors of length of stay in patients hospitalized with heart failure: a report from OPTIMIZE-HF. J Card Fail 2007;13:S156. 21. Fonarow GC, Yancy CW, Albert NM, Curtis A, Gattis Stough W, Gheorghiade M, Heywood JT, McBride ML, Mehra M, O’Connor C, Reynolds D, Walsh MN. Heart failure quality of care in the outpatient cardiology practice setting: a report from IMPROVE HF. J Card Fail 2007;13: S172. 22. Fonarow GC, Yancy CW, Albert NM, Curtis A, Gattis Stough W, Gheorghiade M, Heywood JT, McBride ML. Heart failure quality of care in the outpatient cardiology practice setting: a report from IMPROVE HF. Circulation 2007;116:II273. 23. Fonarow GC, Yancy CW, Albert NM, Curtis A, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra M, O’Connor C, Reynolds D, Walsh MN. Variation in HF quality of care among US outpatient practices: analysis of 131 cardiology practices in IMPROVE HF. J of Card Fail 2007;13:S156. 24. Gage HD, Liu K, Colangelo C, Sniderman A, Lloyd-Jones DM. 20-Year prospective associations between selected lipid parameters in young adulthood and subsequent measures of subclinical atherosclerosis. Circulation 2007;116:II-808. 25. Godreau, A; Liu, K; Daviglus, ML; Colangelo, L; Loria, C; Greenland, P. Cross-sectional association of fasting glucose levels with coronary artery calcium: The coronary artery risk development in youth adults (CARDIA) study. Circulation 2007;115:e286. 26. Gordon L, Singh A, Prachand S., Lieberman E, Sun L, Burke, MA, Naik TJ, Prasad S, Ardehali H. ErbB2 blockade and down regulation lead to cardiomyocyte cell death through distinct pathways. Circulation Res 2007;101:E62. 27. Hankinson, AL; Liu, K; Jacobs, DR; Thyagarajan, B; Smith, LJ; Greenland, P; Sidney, S. Longitudinal changes in cardiorespiratory fitness and pulmonary function over 20 years: The CARDIA study. Circulation 2007;115:e249. 28. Hankinson AL, Lloyd-Jones D, Carnethon MR, Lewis CE, Jacobs DR, Loria C, Sidney S, Liu K. Long-term relation of physical activity with maintenance of a stable body mass index over 20 years: the CARDIA Study. Circulation 2007;116:II-815. 29. Harinstein ME, Ansari AH, Robin J, Rossi J, Flaherty JD, Davidson CJ, Flamm SL, Abecassis MI, Gheorghiade M. Predictive value of dobutamine stress echocardiography for coronary artery disease in liver transplant candidates. Am J Cardiol 2007:100(8). 30. Hutchinson MD, Ilkhanoff L, Cooper JM, Woo YJ, Marchlinski FE, Callans DJ, Jacobson JT. Tissue specific variability in human epicardial impedance. Heart Rhythm Journal 2007;4:S348. 31. Hutchinson MD, Jacobson JT, Silvestry FE, Michele K, Callans DJ, A comparison of intracardiac and transesophageal echocardiography to detect left atrial appendage thrombus in a swine model. Heart Rhythm 2007: 4: S324 32. Ilkhanoff L, Surrey D, Fahssi W, Wolfe D, Marwin V, Averna J, Marchlinski F, Wiegers S, Brozena S, and Cappola TP. Different relationships between conduction delay and ventricular remodeling in men and women with heart failure. J Am Coll Cardiol. 2007;49:98A. 33. Kozak, At; Daviglus, ML; Greenland, P; Chan, CL; Kiefe, CI; Jacobs, DR; Liu, K. Relationship of body mass index in young adulthood and health-related quality of life (HRQoL) in later years: The coronary artery risk development in young adults (CARDIA) study. Circulation 2007;115:e240. 34. Kumar A, Prineas RG, Arnold AM, Psaty BM, Furberg CD, Robbins J, Lloyd-Jones DM. Prevalence, prognosis and implications of isolated non-specific ST-segment and T-wave abnormalities in older adults: Cardiovascular Health Study. Circulation 2007;116:II-820. 35. Lee DC, Johnson NP, O’Hara KC, Harris KR. Correcting curvilinear myocardial signal response to gadolinium improves accuracy of absolute myocardial blood flow quantification by MRI perfusion imaging. Circulation. 2007;116:II-426. 36. Liu XL, Simpson J, Brunt K, Hall S, Kinobe R, Ogunyankin K et al. Pre-emptive heme oxygenase-1 (HO-1) gene delivery reduces mortality and preserves left ventricular function one-year after acute myocardial infarction. Faseb J 2007;21:A1224-A1225. 37. Lloyd-Jones DM, Dyer AR, Liu K, Greenland P. Addition of risk markers to cardiovascular risk prediction scores: do they really add prognostic information? Circulation 2007;115: e268. 38. McManus D, Shah SJ, Fabi M, Whooley MA, Schiller NB. Importance of left ventricular end-systolic volume as a predictor of heart failure hospitalization in patients with coronary heart disease: data from the Heart and Soul Study . J Am Coll Cardiol 2007;49:170A 39. Morse MA, Johnson NP, Davidson CJ, Holly TA. Abnormal myocardial perfusion imaging predicts decreased survival in patients with a negative coronary angiogram. J Am Coll Cardiol 2007;49:109A-110A. 40. Morse MA, Ortiz JT, Bi X, Chung YC, Zuehlsdorf S, Jerecic R, Lee DC, Wu E. A novel method to assess diastolic dysfunction following myocardial infarction based on cine cardiac magnetic resonance imaging. J Cardiovasc Magn Reson. 2007;9:449. 41. Morse MA, Ortiz JT, Lee DC, Kansal P, Wu E. Evaluation of diastolic function with volumetric analysis and mitral inflow velocities following acute myocardial infarction. J Cardiovasc Magn Reson. 2007;9:460. 42. Mosley WJ, Greenland P, Lloyd-Jones DM. Predictive utility of pulse pressure and other blood pressure measures for stroke and heart failure. Circulation 2007;115:e257. 43. Ng J, Borodyanskiy A, Villuendas R, Kadish A, Goldberger J. Using entropy to characterize complex fractionated atrial electrograms during atrial fibrillation. J Am Coll Cardiol 2007;49:10A. 44. Ng J, Kadish A, Goldberger J. Technical considerations for dominant frequency analysis of atrial fibrillation electrograms. J Am Coll Cardiol 2007;49:19A. 45. Ng J, Sundaram S, Kadish A, Goldberger J. Autonomic effects on the spectral analysis of heart rate variability after exercise. J Am Coll Cardiol 2007;49:3A. 46. Ogunyankin K.O, Day A.G, Farrell B. Does arterial waveform analysis further stratify hypertensive patients treated to optimal blood pressure control? J Clin Hypertension 2007 9:Suppl A; P-216. 47. Ogunyankin KO, Day A.G, Londry CC, Lahey K, LaHaye S, Burggraf GW. Comparative event-free prognosis between hemodynamically equivalent clinical and echocardiographic methods for estimating left ventricular filling pressure. J Am Soc of Echocardiog 2007;20:583:P2-18 48. Ogunyankin KO, Farrell B, Londry CC, Day AG, Jiang Xuran. Personalized aggressive blood pressure treatment for 6 months is associated with sustained hypertension control. J Clin Hypertension 2007 9:Suppl A; P-417. 49. Ogunyankin K.O, Lahey K, Londry C.C, Burggraf GW, Day AG, LaHaye S. A validated three-stage classification of left ventricular diastolic function is a better prognosticator of mortality than ejection fraction. J Am Soc Echocardiog 2007;20:581:P2-08 50. Ortiz JT, Lee DC, Kansal P, Bucciarelli-Ducci C, Tejedor P, Wu E. Infarct transmurality and the presence of microvascular obstruction by contrast enhanced cardiac magnetic resonance to predict regional wall motion recovery after myocardial infarction. J Cardiovasc Magn Reson. 2007;9:455. 51. Ortiz JT, Meyers SN, Lee DC, Kansal P, Klocke FJ, Holly TA, Davidson CJ, Bonow RO, Wu E. Angiographic estimates of myocardium at risk during acute myocardial infarction: A validation study using cardiac magnetic resonance imaging. J Am Coll Cardiol 2007;49:105A-106A. 52. Ortiz JT, Rodriguez JF, Kansal P, Meyers SN, Lee DC, Wu E. Correspondence between coronary vasculature and the 17-myocardial segment model. J Cardiovasc Magn Reson. 2007;9:119. 53. Phatak K, Makati K, Holland M, Baig S, Kim M, Link M, Passman R. Should octogenarians who meet criteria receive an ICD? Circulation 2007;116:II-534. 54. Reeves RR, Manuchehry A, Goonewardena SN, Blair JEA, Price A, Rizvi K, Levy A, Gheorghiade M, Spencer KT, Puthumana J, Woodruff J. non-invasive estimation of cardiac filling pressures by residents using tissue doppler imaging and handcarried ultrasount. J Card Fail; 2007;13:S186. 55. Rubenstein JC, Lee DC, Wu E, Kadish A, Passman R, Goldberger J. The prediction of ventricular tachyarrhythmia inducibility by quantification of the peri-infarct border zone by delayed-enhancement cardiac MRI. J Cardiovasc Magn Reson. 2007;9:118. 56. Shah SJ, Bardo DME, Weinert L, Sugeng L, Knight BP, Lopez JJ, Lang RM. Real-time three-dimensional echocardiography of the left atrial appendage: initial experience in humans with validation by 64-slice computed tomography Circulation 2007;116:II-400. 57. Shah SJ, Dayal M, Schiller NB, Whooley MA. Association of increased ventricular and arterial stiffness with reduced exercise capacity: data from the Heart and Soul Study. J Card Fail 2007;13:S90. 58. Shah SJ, Dayal M, Schiller NB, Whooley MA. Chronic kidney disease is associated with increased left ventricular end-systolic stiffness in patients with coronary heart disease: data from the Heart and Soul Study. J Card Fail 2007;13: S150. 59. Shah SJ, Gomberg-Maitland MG, Thenappan T, Archer SL, Rich S. Selective serotonin reuptake inhibitor use is associated with decreased mortality in pulmonary hypertension Circulation 2007;116:II-502. 60. Shah SJ, Ober C, Lang RM. Two-dimensional echocardiography is superior to M-mode for the determination of left ventricular mass: evidence from a heritability study. J Card Fail 2007;13:S175. 61. Shah SJ, Schiller NB, Whooley MA. Abnormalities in left ventricular systolic function predict heart failure events despite normal baseline ejection fraction: data from the Heart and Soul Study. J Am Coll Cardiol 2007;9:122A. 62. Shah SJ, Schiller NB, Whooley MA. Two-dimensional echocardiography is superior to M-mode for the determination of left ventricular mass: evidence from a heart failure outcomes study. J Card Fail 2007;13:S16. 63. Shah SJ, Thenappan T, Rich S, Gomberg-Maitland M. Renal dysfunction predicts mortality in pulmonary arterial hypertension. Am J Resp Crit Care Med 2007;175:A715. 64. Shah SJ, Tingley WT, Zaroff JG, Pawlikowska L, Kwok P, Whooley MA. Dual-specific a kinase anchoring protein 2 polymorphism is associated with increased left ventricular end-systolic elastance in Caucasians. J Am Coll Cardiol 2007;9:52A. 65. Shah SJ, Tingley W, Zaroff JG, Pawlikowska L, Kwok PY, Whooley MA. Genetic determinants of cardiac contractile function in Caucasians J Card Fail 2007;13:S73-74. 66. Shah SJ, Weeks SG, Shapiro M, Foster E, Michaels AD. Intravenous nesiritide decreases contractility in humans: observations from pressure-volume analysis . J Am Coll Cardiol 2007;9:75A. 67. Simpson JA, Liu XL, Brunt KR, Hall SRR, Peng YQ, Ogunyankin KO et al. Hemin enhances cardiac performance in response to pressure overload (PO): implications for treatment of heart failure. FASEB J 2007;21:A1258. 68. Sun L, Shukair S, Naik T, Moazed F, Ardehali H. 2007. Mitochondrial binding and glucose phosphorylation are required for the protective effects of hexokinase I and II. Circ Rese;101: E61-62. 69. Sur J, Shah SJ, Thenappan T, Rich S, Gomberg-Maitland M. Exercise treadmill testing: a powerful predictor of hemodynamics and mortality in pulmonary hypertension. Am J Resp Crit Care Med 2007;175:A402. 70. Swamy R, Shah SJ, Thenappan T, Rich S, Gomberg-Maitland M. Evidence of continued acute vasodilator response after chronic prostacyclin therapy in pulmonary arterial hypertension. Am J Resp Crit Care Med 2007;175: A401. 71. Thenappan T, Shah SJ, Rich S, Archer SL, Gomberg-Maitland M. Survival of patients with pulmonary arterial hypertension in the current era: validation of the National Institutes of Health risk stratification equation. Chest 2007;132:487S. 72. Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M. Pulmonary arterial hypertension: influence of new therapies on tertiary referral. Am J Resp Crit Care Med 2007;175:A398. 73. Udelson JE, Orlandi C, Ouyang J, Krasa H, Zimmer CA, Frivold G, Haught WH, Meymandi S, Wedge P, Konstam MA, Gheorghiade M. Late breaking clinical trials. J Card Fail 2007:13:793-794. 74. Vassallo P, Blankstein R, Arnsdorf MF, Feinstein SB. Beneficial effects of pioglitazonon lipoprotein profiles in nondiabetic patients: initial clinical observations. 75. Villuendas R, Arora R, Cain J, Harvey L, Greene R, Goldberger J, Kadish A. Heterogeneous innervation of the left atrium and pulmonary veins. J Am Coll Cardiol. 2007; 49:20A. 76. Villuendas R, Arora R, Goldstein J, Angulo A, Simon J, Belin R, Aistrup G, Ng J, Greene R, Gordon D, Shade G, Ulphani J, Goldberger J, Kadish A. Atrial autonomic remodeling in a canine model of congestive heart failure. Circulation 2007; 116;II-250. 77. Villuendas R, Kadish A, Lu Y, Bekadesh I, Ng J, Greene R, Gordon D, Goldberger J, Arora R. Heterogeneous distribution of muscarinic receptors contributes to the substrate for vagal atrial fibrillation. Circulation 2007;116;II-279. 78. Villuendas R, Ng J, Mylonas I, Greene R, Mottl S, Gordon D, Goldberger J, Kadish A, Arora R. Selective pharmacologic blockade of parasympathetic innervation in the posterior left atrium modifies substrate for atrial fibrillation. Heart Rhythm 2007;4;5S;S169. 79. Wang N, Ng J, Sen-Gupta I, Kadish A, Goldberger J. How long does sympathetic activation persist after submaximal exercise in subjects with coronary artery disease? J Am Coll Cardiol 2007;49:155A. 80. Wang N, Ng J, Sen-Gupta I, Kadish A, Goldberger J. How long does sympathetic activation persist after submaximal exercise in subjects with coronary artery disease? J Am Coll Cardiol 2007;49:420A. 81. Wang NC, Konstam MA, Gheorghiade M, Bechofer R, Burnett JC, Grinfeld L, Swedberg K, Udelson JE, Cook T, Ouyang J, Simmer C, Orlandi C, Maggioni AP, Zannad F. Regional comparison of baseline therapy in patients hospitalized for acute heart Failure with systolic dysfunction. J Card Fail; 2007;13:S134. 82. Wang NC, Zannad F, Konstam MA, Bechhofer R, Gheorghiade M, Burnett JC, Grinfeld L, Swedberg K, Udelson JE, Cook T, Ouyang J, Zimmer C, Orlandi C, Maggioni AP. The QRS interval predicts mortality and re-hospitalization in patients hospitalized with worsening heart failure and systolic dysfunction. J Card Fail; 2007;13:S142. 83. Wilson PWF, Bhatt DL, Dallongeville J, D’Agostino R, Eagle K, Goto S, Greenland P, Hirsch AT, Liau CS, Ohman EM, Rother J, Reid C, Mas JL, Steg PG, REACH Registry Investigators. An international risk prediction model for recurrent cardiovascular events in the REACH registry. J Am Coll Cardiol 2007;49:396A 84. Wu, R., Burke, M.A., Naik, T.J., Prasad, S.V.N., Ardehali, H. Cytoprotective role of mitochondrial ATP-binding cassette protein-2. Circulation. 2007;116:II 116-117. 85. Yancy CW, Fonarow GC, Albert NM, Curtis A, Gattis Stough W, Gheorghiade M, Heywood JT, McBride ML, Mehra M, O’Connor C, Reynolds D, Walsh MN. Outpatient documentation of NYHA functional class and/or activity level in HF patients: a report from IMPROVE HF. J Cardi Fail; 2007;13:S176. 86. Yancy CW, Fonarow GC, Curtis AA, Gatis Stough, CW, Gheorghiade M, Heywood JT, McBride ML, Mehra M, O’Connor C, Reynolds D, Walsh MN. Are patient age and gender associated with delivery of recommended HF therapies? J Card Fail;2007;13:S158. 87. Zhao Q, McCarthy P, Kane BJ, Bonow RO, Rigolin, VH. Identification of differential patterns of left ventricular and left atrial remodeling following mitral valve repair for chronic mitral regurgitation using comprehensive echocardiographic imaging. J Am Soc Echocardiogr 2007; 20:559.
1. Holly TA Kansal P. Basic properties of myocardial perfusion agents. In: Rose, BD,ed. UpToDate, Waltham, MA, 2007. 2. Passman R, Mangrum M, Herzog C. Sudden cardiac death in dialysis patients. In: Rose, BD, ed. UpToDate, Waltham, MA, 2007
|
